中国银屑病患者饮食管理指南（2023）

doi:10.35541/cjd.20220913

Abstract

Abstract: 【Abstract】 The prevalence of psoriasis in China is witnessing an upward trend in recent years. Diet is one of the vital factors associated with patients′ quality of life, but there is still a lack of standardized instructions. Hence, it is of great importance to develop an evidence-based guideline for dietary management among Chinese patients with psoriasis. This guideline was jointly endorsed by the China Dermatologist Association and the Chinese Society of Dermatology. A working group composed of experts in the fields of dermatology, nutriology, and evidence-based methodology developed this guideline following the standardized process of formulating clinical evidence-based guidelines. This guideline provides 17 evidence-based recommendations on 12 clinical issues of great concern to dermatologists and patients, aiming to provide more scientific and reasonable dietary interventions for patients with psoriasis.

Key words: Psoriasis, Diet, Guideline

China Dermatologist Association, Chinese Society of Dermatology, Xijing Hospital, Air Force Medical University, Chinese Dietary Guideline for Psoriasis Patients Task Force. Dietary guideline for patients with psoriasis in China （2023）[J]. Chinese Journal of Dermatology, 2023, 56(5): 389-401.doi:10.35541/cjd.20220913

References ［78］

［1］	Armstrong A W, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review［J］. JAMA, 2020,323（19）:1945⁃1960. doi: 10.1001/jama.2020.4006.
［2］	Leung YY, Tam LS, Li EK. The perspective on psoriatic arthritis in Asia［J］. Curr Rheumatol Rep, 2011,13（4）:369⁃375. doi: 10.1007/s11926⁃011⁃0183⁃9.
［3］	Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population⁃based study in six cities［J］. Eur J Dermatol, 2012,22（5）:663⁃667. doi: 10.1684/ejd.2012.1802.
［4］	Griffiths C, Armstrong AW, Gudjonsson JE, et al. Psoriasis［J］. Lancet, 2021,397（10281）:1301⁃1315. doi: 10.1016/S0140⁃6736（20）32549⁃6.
［5］	Holmannova D, Borska L, Andrys C, et al. The impact of psoriasis and metabolic syndrome on the systemic inflammation and oxidative damage to nucleic acids［J］. J Immunol Res, 2020,2020:1⁃9. doi: 10.1155/2020/7352637.
［6］	Polic M V, Miskulin M, Smolic M, et al. Psoriasis severity⁃a risk factor of insulin resistance independent of metabolic syndrome［J］. Int J Environ Res Public Health, 2018,15（7）:1486. doi: 10.3390/ijerph15071486.
［7］	Zusman E Z, Howren A M, Park J Y E, et al. Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta⁃analysis［J］. Semin Arthritis Rheum, 2020, 50（6）: 1481⁃1488. doi: 10.1016/j.semarthrit.2020.02.001.
［8］	Elmets CA, Leonardi CL, Davis D, et al. Joint AAD⁃NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities［J］. J Am Acad Dermatol, 2019,80（4）:1073⁃1113. doi: 10.1016/j.jaad.2018.11. 058.
［9］	Wolters M. Diet and psoriasis: experimental data and clinical evidence［J］. Br J Dermatol, 2005,153（4）:706⁃714. doi: 10. 1111/j.1365⁃2133.2005.06781.x.
［10］	Garbicz J, Całyniuk B, Górski M, et al. Nutritional therapy in persons suffering from psoriasis［J］. Nutrients, 2021,14（1）:119. doi: 10.3390/nu14010119.
［11］	Afifi L, Danesh M J, Lee K M, et al. Dietary behaviors in psoriasis: patient⁃reported outcomes from a u.s. national survey［J］. Dermatol Ther （Heidelb）, 2017,7（2）:227⁃242. doi: 10.1007/ s13555⁃017⁃0183⁃4.
［12］	Bridgman AC, Qureshi AA, Li T, et al. Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: a cohort study［J］. J Am Acad Dermatol, 2019,80（6）:1682⁃1690. doi: 10.1016/j.jaad.2019.02.038.
［13］	Drucker AM, Qureshi AA, Thompson JM, et al. Gluten intake and risk of psoriasis, psoriatic arthritis, and atopic dermatitis among United States women［J］. J Am Acad Dermatol, 2020,82（3）:661⁃665. doi: 10.1016/j.jaad.2019.08.007.
［14］	Ford A R, Siegel M, Bagel J, et al. Dietary recommendations for adults with psoriasis or psoriatic arthritis from the medical board of the national psoriasis foundation: a systematic review［J］. JAMA Dermatol, 2018, 154（8）: 934⁃950. doi: 10.1001/jamadermatol. 2018.1412.
［15］	朱冠男, 徐峰, 俞晨, 等. 对中国皮肤科医生关于饮食影响银屑病的认知调查: 一项横断面分析［J］. 中华皮肤科杂志, 2021,54（10）:891⁃897. doi: 10.35541/cjd.20200540.
［16］	朱慧琴, 仲珣, 王洋, 等. 银屑病312例与代谢综合征相关性的临床分析［J］. 中国皮肤性病学杂志, 2019,33（4）:425⁃430. doi: 10.13735/j.cjdv.1001⁃7089.201804097.
［17］	毛荣超, 陈新春, 卢玉龙, 等. 贵州黔南地区农村少数民族居民银屑病患病现状及其危险因素分析［J］. 中国公共卫生, 2019,35（1）:34⁃37. doi: 10.11847/zgggws1117664.
［18］	Lenoir H, Erbland A, Lumens D, et al. Trapeziectomy and ligament reconstruction tendon interposition after failed trapeziometacarpal joint replacement［J］. Hand Surg Rehabil, 2016,35（1）:21⁃26. doi: 10.1016/j.hansur.2015.09.002.
［19］	Ogawa K, Stuart P E, Tsoi L C, et al. A transethnic mendelian randomization study identifies causality of obesity on risk of psoriasis［J］. J Invest Dermatol, 2019,139（6）:1397⁃1400. doi: 10.1016/j.jid.2018.11.023.
［20］	Eder L, Thavaneswaran A, Chandran V, et al. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis［J］. Ann Rheum Dis, 2015,74（5）:813⁃817. doi: 10. 1136/annrheumdis⁃2013⁃204448.
［21］	Enos C W, Ramos V L, McLean R R, et al. Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: a prospective analysis in corrona psoriasis registry［J］. J Am Acad Dermatol, 2022,86（1）:68⁃76. doi: 10.1016/j.jaad.2021.06.883.
［22］	Paroutoglou K, Papadavid E, Christodoulatos G S, et al. Deciphering the association between psoriasis and obesity: current evidence and treatment considerations［J］. Curr Obes Rep, 2020,9（3）:165⁃178. doi: 10.1007/s13679⁃020⁃00380⁃3.
［23］	Aune D, Snekvik I, Schlesinger S, et al. Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose⁃response meta⁃analysis of prospective studies［J］. Eur J Epidemiol, 2018,33（12）:1163⁃1178. doi: 10.1007/s10654⁃018⁃0366⁃z.
［24］	Phan K, Lee G, Fischer G. Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: systematic review and meta⁃analysis［J］. Pediatr Dermatol, 2020,37（4）:661⁃669. doi: 10.1111/pde.14208.
［25］	Xie W, Huang H, Deng X, et al. Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta⁃analysis of observational studies［J］. J Am Acad Dermatol, 2021,84（3）:701⁃711. doi: 10.1016/j.jaad.2020.08.060.
［26］	Mahil SK, McSweeney SM, Kloczko E, et al. Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic［J］. Br J Dermatol, 2019,181（5）:946⁃953. doi: 10.1111/bjd.17741.
［27］	Mourad A, Straube S, Armijo⁃Olivo S, et al. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2019,181（3）:450⁃458. doi: 10.1111/bjd.17738.
［28］	Shan J, Zhang J. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta⁃analysis［J］. Joint Bone Spine, 2019,86（2）:173⁃183. doi: 10.1016/j.jbspin.2018.03.007.
［29］	Ricceri F, Chiricozzi A, Peris K, et al. Successful use of anti⁃IL⁃23 molecules in overweight⁃to⁃obese psoriatic patients: a multicentric retrospective study［J］. Dermatol Ther, 2022,35（11）:e15793. doi: 10.1111/dth.15793.
［30］	Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis［J］. Lancet, 2007,370（9583）:263⁃271. doi: 10.1016/S0140⁃6736（07）61128⁃3.
［31］	Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome［J］. Lancet, 2005,365（9468）:1415⁃1428. doi: 10.1016/S0140⁃6736（05）66378⁃7.
［32］	Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta⁃analysis of observational studies［J］. J Am Acad Dermatol, 2013,68（4）:654⁃662. doi: 10.1016/j.jaad.2012.08.015.
［33］	Upala S, Sanguankeo A. Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta⁃analysis［J］. Int J Obes （Lond）, 2015,39（8）:1197⁃1202. doi: 10.1038/ijo.2015.64.
［34］	Jensen P, Zachariae C, Christensen R, et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study［J］. JAMA Dermatol, 2013,149（7）:795⁃801. doi: 10.1001/jamadermatol. 2013.722.
［35］	Jensen P, Zachariae C, Christensen R, et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis［J］. Acta Derm Venereol, 2014,94（6）:691⁃694. doi: 10.2340/00015555⁃1824.
［36］	Naldi L, Conti A, Cazzaniga S, et al. Diet and physical exercise in psoriasis: a randomized controlled trial［J］. Br J Dermatol, 2014,170（3）:634⁃642. doi: 10.1111/bjd.12735.
［37］	Di Minno MN, Peluso R, Iervolino S, et al. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers［J］. Ann Rheum Dis, 2014,73（6）:1157⁃1162. doi: 10.1136/annrheumdis⁃2012⁃202812.
［38］	Guida B, Napoleone A, Trio R, et al. Energy⁃restricted, n⁃3 polyunsaturated fatty acids⁃rich diet improves the clinical response to immuno⁃modulating drugs in obese patients with plaque⁃type psoriasis: a randomized control clinical trial［J］. Clin Nutr, 2014,33（3）:399⁃405. doi: 10.1016/j.clnu.2013.09. 010.
［39］	Al⁃Mutairi N, Nour T. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial［J］. Expert Opin Biol Ther, 2014,14（6）:749⁃756. doi: 10.1517/14712598. 2014.900541.
［40］	Del Giglio M, Gisondi P, Tessari G, et al. Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator⁃blinded study［J］. Dermatology, 2012,224（1）:31⁃37. doi: 10.1159/0003 35566.
［41］	Gisondi P, Del Giglio M, Di Francesco V, et al. Weight loss improves the response of obese patients with moderate⁃to⁃severe chronic plaque psoriasis to low⁃dose cyclosporine therapy: a randomized, controlled, investigator⁃blinded clinical trial［J］. Am J Clin Nutr, 2008,88（5）:1242⁃1247. doi: 10.3945/ajcn.2008. 26427.
［42］	Kimball AB, Alavian C, Alora⁃Palli M, et al. Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy［J］. J Eur Acad Dermatol Venereol, 2012,26（12）:1582⁃1584. doi: 10.1111/j.1468⁃3083. 2011.04361.x.
［43］	Green A, Shaddick G, Charlton R, et al. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis［J］. Br J Dermatol, 2020,182（3）:714⁃720. doi: 10.1111/bjd. 18227.
［44］	Patients who misuse alcohol have poorer responses to systemic treatments for psoriasis［J］. Br J Dermatol, 2021,185（5）:e179⁃e198. doi: 10.1111/bjd.20717.
［45］	Wang Q, Luo Y, Chen M, et al. Comparison of behavioral risk factors and cardiometabolic comorbidities of psoriatic arthritis and psoriasis: a case⁃control study in chinese patients［J］. Ther Clin Risk Manage, 2021,17:397⁃404. doi: 10.2147/TCRM.S30 7102.
［46］	郑雨萍, 柏丁兮, 高静, 等. 中国居民银屑病发病危险因素的meta分析［J］. 现代临床医学, 2021,47（6）:433⁃435,440. doi: 10.11851/j.issn.1673⁃1557.2021.06.011.
［47］	Brenaut E, Horreau C, Pouplard C, et al. Alcohol consumption and psoriasis: a systematic literature review［J］. J Eur Acad Dermatol Venereol, 2013,27 Suppl 3:30⁃35. doi: 10.1111/jdv. 12164.
［48］	Zhu KJ, Zhu CY, Fan YM. Alcohol consumption and psoriatic risk: a meta⁃analysis of case⁃control studies［J］. J Dermatol, 2012,39（9）:770⁃773. doi: 10.1111/j.1346⁃8138.2012.01577.x.
［49］	Rodríguez⁃Zúñiga M, García⁃Perdomo HA. Systematic review and meta⁃analysis of the association between psoriasis and metabolic syndrome［J］. J Am Acad Dermatol, 2017,77（4）:657⁃666.e8. doi: 10.1016/j.jaad.2017.04.1133.
［50］	Aune D, Giovannucci E, Boffetta P, et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all⁃cause mortality⁃a systematic review and dose⁃response meta⁃analysis of prospective studies［J］. Int J Epidemiol, 2017,46（3）:1029⁃1056. doi: 10.1093/ije/dyw319.
［51］	尚智伟, 李其林, 付金玲, 等. 国内银屑病发病危险因素的Meta分析［J］. 岭南皮肤性病科杂志, 2009,16（3）:161⁃163. doi: 10.3969/j.issn.1674⁃8468.2009.03.007.
［52］	Ingkapairoj K, Chularojanamontri L, Chaiyabutr C, et al. Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets［J］. J Dermatolog Treat, 2022,33（4）:2290⁃2296. doi: 10.1080/09546634.2021.1959500.
［53］	Naldi L, Parazzini F, Peli L, et al. Dietary factors and the risk of psoriasis. results of an italian case⁃control study［J］. Br J Dermatol, 1996,134（1）:101⁃106. doi: 10.1046/j.1365⁃2133.1996. d01⁃734.x.
［54］	楼燕凤. 银屑病复发相关因素分析及自我管理的探析［D］. 东南大学, 2020.
［55］	徐巧虎. 不同时期银屑病患者流行病学调查及临床资料的多元回归分析［D］. 安徽医科大学, 2019.
［56］	杨桂兰, 苏湘川, 潘之, 等. 甘肃地区寻常性银屑病病情相关因素分析［J］. 实用皮肤病学杂志, 2016,9（2）:101⁃103. doi: 10.11786/sypfbxzz.1674⁃1293.20160206.
［57］	Phan C, Touvier M, Kesse⁃Guyot E, et al. Association between mediterranean anti⁃inflammatory dietary profile and severity of psoriasis: results from the nutrinet⁃santé cohort［J］. JAMA Dermatol, 2018, 154（9）: 1017⁃1024. doi: 10.1001/jamadermatol. 2018.2127.
［58］	Barrea L, Balato N, Di Somma C, et al. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the mediterranean diet?［J］. J Transl Med, 2015,13（1）:18. doi: 10.1186/s12967⁃014⁃0372⁃1.
［59］	Park MK, Li W, Paek SY, et al. Consumption of polyunsaturated fatty acids and risk of incident psoriasis and psoriatic arthritis from the Nurses′ Health Study II［J］. Br J Dermatol, 2017,177（1）:302⁃306. doi: 10.1111/bjd.15059.
［60］	乔菊, 贾倩楠, 李峰, 等. 寻常性银屑病患者饮食危险因素流行病学调查［J］. 中国皮肤性病学杂志, 2017,31（12）:1301⁃1305. doi: 10.13735/j.cjdv.1001⁃7089.201703159.
［61］	庞春坤, 高婷婷. 中国人群银屑病发病危险因素的Meta分析［J］. 中国麻风皮肤病杂志, 2013,29（4）:235⁃238.
［62］	李玉湘, 傅强, 张秀春, 等. 青海高原地区108例银屑病临床分析［J］. 青海医药杂志, 2012,42（12）:20⁃21.
［63］	袁爱红, 杨骏. 高脂饮食的研究进展［J］. 医学综述, 2012,18（15）:2418⁃2421. doi: 10.3969/j.issn.1006⁃2084.2012.15.026.
［64］	Yazdanpanah MJ, Vahabi⁃Amlashi S, Nematy M, et al. Association of serum lipid profiles and dietary intakes of vitamin E and fiber with psoriasis severity［J］. Caspian J Intern Med, 2021,12（4）:606⁃612. doi: 10.22088/cjim.12.4.606.
［65］	Pinto B, Pereira P, Ramalho R. Characterization of food intake in patients with psoriasis［J］. Clinical Nutrition ESPEN, 2021, 46: S627. doi: 10.1016/j.clnesp.2021.09.242.
［66］	钱园. 寻常性银屑病患者饮食危险因素流行病学调查［J］. 饮食保健, 2018,5（41）:288⁃289. doi: 10.3969/j.issn.2095⁃8439. 2018.41.361. doi: 10.3969/j.issn.2095⁃8439.2018.41.361.
［67］	Leite BF, Morimoto MA, Gomes C, et al. Dietetic intervention in psoriatic arthritis: the DIETA trial［J］. Adv Rheumatol, 2022,62（1）:12. doi: 10.1186/s42358⁃022⁃00243⁃6.
［68］	Kharaeva Z, Gostova E, De Luca C, et al. Clinical and biochemical effects of coenzyme Q（10）, vitamin E, and selenium supplementation to psoriasis patients［J］. Nutrition, 2009,25（3）:295⁃302. doi: 10.1016/j.nut.2008.08.015.
［69］	Gaál J, Lakos G, Szodoray P, et al. Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow⁃up pilot study［J］. Acta Derm Venereol, 2009,89（2）:140⁃144. doi: 10.2340/00015555⁃0555.
［70］	Madland TM, Björkkjaer T, Brunborg LA, et al. Subjective improvement in patients with psoriatic arthritis after short⁃term oral treatment with seal oil. A pilot study with double blind comparison to soy oil［J］. J Rheumatol, 2006,33（2）:307⁃310.
［71］	Kristensen S, Schmidt EB, Schlemmer A, et al. Beneficial effect of n⁃3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo⁃controlled trial［J］. Scand J Rheumatol, 2018,47（1）:27⁃36. doi: 10.1080/03009742.2017.1287304.
［72］	Veale D J, Torley H I, Richards I M, et al. A double⁃blind placebo controlled trial of efamol marine on skin and joint symptoms of psoriatic arthritis［J］. Rheumatology, 1994,33（10）:954⁃958. doi: 10.1093/rheumatology/33.10.954.
［73］	Graziano M, Rossi M. An update on the cutaneous manifestations of coeliac disease and non⁃coeliac gluten sensitivity［J］. Int Rev Immunol, 2018,37（6）:291⁃300. doi: 10. 1080/08830185.2018.1533008.
［74］	Michaëlsson G, Gerdén B, Ottosson M, et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin［J］. Br J Dermatol, 1993,129（6）:667⁃673. doi: 10.1111/j.1365⁃2133.1993.tb03329.x.
［75］	Bell K A, Pourang A, Mesinkovska N A, et al. The effect of gluten on skin and hair: a systematic review［J］. Dermatol Online J, 2021, 27（4）: 13030/qt2qz916r0. doi: 10.5070/D3274053148.
［76］	Michaëlsson G, Kristjánsson G, Pihl Lundin I, et al. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten⁃free diet［J］. Br J Dermatol, 2007,156（4）:659⁃666. doi: 10.1111/j.1365⁃2133.2006. 07725.x.
［77］	Stegenga H, Haines A, Jones K, et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance［J］. BMJ, 2014,349:g6608. doi: 10.1136/bmj.g6608.
［78］	Hoelscher DM, Kirk S, Ritchie L, et al. Position of the Academy of Nutrition and Dietetics: interventions for the prevention and treatment of pediatric overweight and obesity［J］. J Acad Nutr Diet, 2013,113（10）:1375⁃1394. doi: 10.1016/j.jand.2013.08.004.

[1]	Shan Ying, Chang Xiaotong, Zuo Yagang. Epitope spreading in autoimmune bullous diseases [J]. Chinese Journal of Dermatology, 2023, 56(7): 702-705.
[2]	Jiang Xiaoyan, Gao Min, Zhang Xiaoyan, Liu Ningyuan. Interleukin-17 and interleukin-23 inhibitors in the treatment of pustular psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(7): 689-692.
[3]	Tang Zhiming, Jing Mengqing, Lu Lu, Shan Xiao, Zhang Cuixia, Zhang Xiaoyu, Meng Sa. Effect of Xidi Liangxue recipe on the proliferation and apoptosis of HaCaT cells through the lncRNA NEAT1/miR-485-5p/STAT3 regulatory network [J]. Chinese Journal of Dermatology, 2023, 56(7): 642-650.
[4]	Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2023 edition） [J]. Chinese Journal of Dermatology, 2023, 56(7): 573-625.
[5]	Jia Weixue, Li Chengrang. Comparison of Chinese and international guidelines and consensus for the diagnosis and treatment of vitiligo [J]. Chinese Journal of Dermatology, 2023, 56(5): 471-475.
[6]	Jin Liping, Zhu Wu, Lu Yan, Liu Panpan, Tan Minjia, Wang Ying, Yang Jing, Xu Licong, Hu Kun, Kuang Yehong. Dietary intervention for the treatment of psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(4): 357-360.
[7]	Lian Panpan, Liu Jun, Su Zhonglan, Wang Hongwei. Effect of peroxisome proliferator-activated receptor γ on skin physiological and pathological processes [J]. Chinese Journal of Dermatology, 2023, 56(4): 365-368.
[8]	Ruan Shifan, Zhang Peng, Lin Tingting, Luo Renwei, Bao Siyi, Xue Chenyao, Tong Zequn, Zhang Liangliang, Gong Ting, Ji Chao, . Correlations between psoriasis vulgaris and dyslipidemia [J]. Chinese Journal of Dermatology, 2023, 0(3): 20220322-e20220322.
[9]	Committee on Psoriasis, Chinese Society of Dermatology. Expert consensus on treat-to-target approach for the treatment of psoriasis with biological agents [J]. Chinese Journal of Dermatology, 2023, 56(3): 191-203.
[10]	Zhou Jian, Yu Chen, Wang Gang. Clinical efficacy and safety of secukinumab in the treatment of 13 cases of refractory localized pustular psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(3): 247-251.
[11]	Hu Kun, Yang Jing, Wang Qiaolin, Chen Junchen, Zhang Mi, Zhu Wu, Zhang Bin, Dou Guanshen, Wendong Chen, Kuang Yehong. Real-world short-term treatment effects of Ixekizumab in Chinese patients with psoriasis: a single-center retrospective study [J]. Chinese Journal of Dermatology, 2023, 56(3): 210-215.
[12]	Liu Xiaoyang, Zhao Yan, Cai Lin, Zhang Jianzhong. Atopic dermatitis-like lesions appearing after interleukin-17 antagonist therapy in 4 cases of psoriasis: case analysis and literature review [J]. Chinese Journal of Dermatology, 2023, 0(3): 20210794-e20210794.
[13]	He Xie, Li Yuzhen. Targeting the JAK-STAT signaling pathway in the treatment of psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(3): 273-278.
[14]	Wang Zhaoyang, Xiang Xin, Chen Yunliu, Miao Chaoyang, Zhao Xinrong, Zhang Zhenhua, Liu Yuanxiang, Ma Lin, Xu Zigang. Comparison of efficacy and safety of biologics versus methotrexate in the treatment of severe pediatric plaque psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(2): 112-117.
[15]	Yang Qi, Zheng Jie. Effect of biologics on cardiovascular comorbidities of psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(2): 165-169.

Dietary guideline for patients with psoriasis in China （2023）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［78］

Related Articles 15

Metrics

Comments

Recommended 10